Form 8-K - Current report:
SEC Accession No. 0000950103-25-007605
Filing Date
2025-06-18
Accepted
2025-06-18 16:58:34
Documents
14
Period of Report
2025-06-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp229898_8k.htm   iXBRL 8-K 30178
2 EXHIBIT 99.1 dp229898_ex9901.htm EX-99.1 12024
6 GRAPHIC image_001.jpg GRAPHIC 18601
  Complete submission text file 0000950103-25-007605.txt   239679

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bhc-20250609.xsd EX-101.SCH 3023
4 XBRL PRESENTATION FILE bhc-20250609_pre.xml EX-101.PRE 22365
5 XBRL LABEL FILE bhc-20250609_lab.xml EX-101.LAB 34239
17 EXTRACTED XBRL INSTANCE DOCUMENT dp229898_8k_htm.xml XML 3669
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 251057636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)